Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHOCKEM-Blue: Methylene Blue in Septic Shock
NCT04446871Phase 3Completed
- Sponsor
- Hospital Civil de Guadalajara
- Start
- Mar 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of methylene blue in septic shock (2 arms), sponsored by Hospital Civil de Guadalajara. Primary endpoint: Vasopressor requirement at 28 days. Started Mar 2017; status: completed.
02
Drugs
methylene blue
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT04446871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04446871.